Pharmaceuticals & Biotech Canadian Companies

Blueberries Medical

Market Cap: CA$9.9m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

Rakovina Therapeutics

Market Cap: CA$9.9m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

Avant Brands

Market Cap: CA$10.2m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Glow Lifetech

Market Cap: CA$10.2m

A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.

Lobe Sciences

Market Cap: CA$11.2m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

Medicure

Market Cap: CA$12.0m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Innovotech

Market Cap: CA$12.0m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Christina Lake Cannabis

Market Cap: CA$12.4m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

SOL Global Investments

Market Cap: CA$12.6m

A private equity firm specializing in emerging growth.

COSCIENS Biopharma

Market Cap: CA$13.4m

A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.

Nextleaf Solutions

Market Cap: CA$13.5m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Pharmala Biotech Holdings

Market Cap: CA$14.4m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Cytophage Technologies

Market Cap: CA$15.4m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States, Canada, and international territories.

Marvel Biosciences

Market Cap: CA$17.7m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Ayr Wellness

Market Cap: CA$18.1m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

BriaCell Therapeutics

Market Cap: CA$18.8m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Hemostemix

Market Cap: CA$20.0m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Charlotte's Web Holdings

Market Cap: CA$21.5m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

PreveCeutical Medical

Market Cap: CA$22.8m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Telescope Innovations

Market Cap: CA$23.1m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Rapid Dose Therapeutics

Market Cap: CA$23.3m

A life sciences company, provides drug delivery technologies in Canada.

1CM

Market Cap: CA$27.7m

Operates as a multi-jurisdictional cannabis company in Canada.

Devonian Health Group

Market Cap: CA$27.9m

Engages in the development of botanical drugs.

Light AI

Market Cap: CA$28.2m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Resverlogix

Market Cap: CA$29.4m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Voyageur Pharmaceuticals

Market Cap: CA$29.4m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Sharp Therapeutics

Market Cap: CA$30.0m

A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.

Greenway Greenhouse Cannabis

Market Cap: CA$30.4m

Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.

Microbix Biosystems

Market Cap: CA$32.9m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Avicanna

Market Cap: CA$33.0m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

MediPharm Labs

Market Cap: CA$33.7m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

PharmaTher Holdings

Market Cap: CA$34.6m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

Gemina Laboratories

Market Cap: CA$37.5m

A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.